Radiographically determined noninvasive adenocarcinoma of the lung: Survival outcomes of Japan Clinical Oncology Group 0201  Hisao Asamura, MD, Tomoyuki.

Slides:



Advertisements
Similar presentations
Prognostic impacts of EGFR mutation status and subtype in patients with surgically resected lung adenocarcinoma  Kazuya Takamochi, MD, Shiaki Oh, MD,
Advertisements

Limited resection trial for pulmonary ground-glass opacity nodules: Fifty-case experience  Junji Yoshida, MD, Kanji Nagai, MD, Tomoyuki Yokose, MD, Mitsuyo.
The eighth edition TNM stage classification for lung cancer: What does it mean on main street?  Frank C. Detterbeck, MD  The Journal of Thoracic and Cardiovascular.
A Proposal for Definition of Minimally Invasive Adenocarcinoma of the Lung Regardless of Tumor Size  Shigeki Suzuki, MD, Hiroyuki Sakurai, MD, Kyohei.
Limited resection trial for pulmonary ground-glass opacity nodules: Fifty-case experience  Junji Yoshida, MD, Kanji Nagai, MD, Tomoyuki Yokose, MD, Mitsuyo.
Lung cancer screening: No more excuses
Interventional radiology suite or hybrid operating room: Which is the best for lung nodule localization?  Robert B. Cameron, MD  The Journal of Thoracic.
Multicenter analysis of high-resolution computed tomography and positron emission tomography/computed tomography findings to choose therapeutic strategies.
Radical sublobar resection for small-sized non–small cell lung cancer: A multicenter study  Morihito Okada, MD, PhD, Teruaki Koike, MD, PhD, Masahiko.
Outcomes of unexpected pathologic N1 and N2 disease after video-assisted thoracic surgery lobectomy for clinical stage I non–small cell lung cancer  Hong.
Ground glass opacity of the lung: The veil that needs lifting
Neither Maximum Tumor Size nor Solid Component Size Is Prognostic in Part-Solid Lung Cancer: Impact of Tumor Size Should Be Applied Exclusively to Solid.
Importance of Ground Glass Opacity Component in Clinical Stage IA Radiologic Invasive Lung Cancer  Aritoshi Hattori, MD, Takeshi Matsunaga, MD, Kazuya.
Oncological Characteristics of Radiological Invasive Adenocarcinoma with Additional Ground-Glass Nodules on Initial Thin-Section Computed Tomography:
Clinicopathologic Features of Resected Subcentimeter Lung Cancer
How Long Should Small Lung Lesions of Ground-Glass Opacity be Followed?  Yoshihisa Kobayashi, MD, Takayuki Fukui, MD, Simon Ito, MD, Noriyasu Usami, MD,
Lung Cancer with Localized Ground-Glass Attenuation Represents Early-Stage Adenocarcinoma in Nonsmokers  Nobuhiko Seki, MD, Shigeki Sawada, MD, Masao.
Prognostic Impact of the Findings on Thin-Section Computed Tomography in Patients with Subcentimeter Non–Small Cell Lung Cancer  Aritoshi Hattori, MD,
Propensity score–matched analysis of adjuvant chemotherapy for stage I non–small cell lung cancer  Yasuhiro Tsutani, MD, PhD, Yoshihiro Miyata, MD, PhD,
The prognostic role of pathologic invasive component size, excluding lepidic growth, in stage I lung adenocarcinoma  Yasuhiro Tsutani, MD, PhD, Yoshihiro.
Influence of Cigarette Smoking on Survival and Tumor Invasiveness in Clinical Stage IA Lung Adenocarcinoma  Ryo Maeda, MD, Junji Yoshida, MD, Genichiro.
Esophagectomy versus endoscopic resection for patients with early-stage adenocarcinoma: Mercedes versus Tesla  Toni Lerut, MD  The Journal of Thoracic.
Certification in cardiothoracic surgical critical care: A distinction for some or for all?  Nicholas D. Andersen, MD  The Journal of Thoracic and Cardiovascular.
A prematurely terminated phase III trial of intraoperative intrapleural hypotonic cisplatin treatment in patients with resected non-small cell lung cancer.
STAT3, Cten, and lung cancer: Simultaneous excitement and caution
Segmentectomy for selected cT1N0M0 non–small cell lung cancer: A prospective study at a single institute  Hiroaki Nomori, PhD, Takeshi Mori, PhD, Koei.
Lung adenocarcinoma: Are skip N2 metastases different from non-skip?
A clinicopathological study of resected subcentimeter lung cancers: a favorable prognosis for ground glass opacity lesions  Hisao Asamura, MD, Kenji Suzuki,
Radiologic Classification of Small Adenocarcinoma of the Lung: Radiologic-Pathologic Correlation and Its Prognostic Impact  Kenji Suzuki, MD, Masahiko.
Juan N. Pulido, MD  The Journal of Thoracic and Cardiovascular Surgery 
Extratumoral Vascular Invasion Is a Significant Prognostic Indicator and a Predicting Factor of Distant Metastasis in Non-small Cell Lung Cancer  Yoshihisa.
Solid tumors versus mixed tumors with a ground-glass opacity component in patients with clinical stage IA lung adenocarcinoma: Prognostic comparison using.
Clinicopathological Characteristics of Screen-Detected Lung Cancers
It's not “just a shunt” but sometimes it should be…
A first start for lung transplantation?
Navigating the lung for hidden treasure
Pulmonary Resection in Patients Aged 80 Years or Over with Clinical Stage I Non-small Cell Lung Cancer: Prognostic Factors for Overall Survival and Risk.
Visceral Pleural Invasion Classification in Non-small Cell Lung Cancer
Ground-glass opacities: A curable disease but a big challenge for surgeons  Ugo Cioffi, MD, PhD, Federico Raveglia, MD, Matilde De Simone, MD, PhD, Alessandro.
Clinicopathologic Features and Computed Tomographic Findings of 52 Surgically Resected Adenosquamous Carcinomas of the Lung  Yukio Watanabe, MD, Koji.
Resection of primary lung cancer with incidental pleural seeding: Seeds of change or reap what you sow?  Jules Lin, MD  The Journal of Thoracic and Cardiovascular.
Derrick Y. Tam, MD, Stephen E. Fremes, MD, MSc 
The Prognostic Impact of Cigarette Smoking on Patients with Non-small Cell Lung Cancer  Ryo Maeda, MD, Junji Yoshida, MD, PhD, Genichiro Ishii, MD, PhD,
A fate worse than death  Jennifer S. Lawton, MD 
“Early” peripheral lung cancer: prognostic significance of ground glass opacity on thin- section computed tomographic scan  Kenji Suzuki, MD, Hisao Asamura,
Video-assisted resection for lung cancer results in fewer complications  Lunxu Liu, PhD, MD, FRCS  The Journal of Thoracic and Cardiovascular Surgery 
Prognosis of Resected Non-Small Cell Lung Cancer Patients with Intrapulmonary Metastases  Kanji Nagai, MD, Yasunori Sohara, MD, Ryosuke Tsuchiya, MD,
Visceral Pleura Invasion Impact on Non-small Cell Lung Cancer Patient Survival: Its Implications for the Forthcoming TNM Staging Based on a Large-Scale.
Long-Term Outcomes of 50 Cases of Limited-Resection Trial for Pulmonary Ground- Glass Opacity Nodules  Masayuki Nakao, MD, Junji Yoshida, MD, PhD, Koichi.
Phase II trial of postoperative adjuvant cisplatin and etoposide in patients with completely resected stage I-IIIa small cell lung cancer: The Japan Clinical.
Passing the torch The Journal of Thoracic and Cardiovascular Surgery
Lobe-Specific Nodal Dissection for Clinical Stage I and II NSCLC: Japanese Multi- Institutional Retrospective Study Using a Propensity Score Analysis 
Clinical and Pathological Staging Validation in the Eighth Edition of the TNM Classification for Lung Cancer: Correlation between Solid Size on Thin-Section.
Innovation in cardiothoracic surgical training
Multifocal lung cancer within ground glass lesions: Are favorable outcomes consequent to surgical resection or inherent to the disease?  Mara B. Antonoff,
Bryan M. Burt, MD  The Journal of Thoracic and Cardiovascular Surgery 
The Journal of Thoracic and Cardiovascular Surgery
Discussion The Journal of Thoracic and Cardiovascular Surgery
The future of cardiac surgery training: A survival guide
Influence of Ground Glass Opacity and the Corresponding Pathological Findings on Survival in Patients with Clinical Stage I Non–Small Cell Lung Cancer 
Tumor invasiveness as defined by the newly proposed IASLC/ATS/ERS classification has prognostic significance for pathologic stage IA lung adenocarcinoma.
“The more things change…”: The challenges ahead
Aritoshi Hattori, MD, Kenji Suzuki, MD 
Prognostic Role of Positron Emission Tomography and High-Resolution Computed Tomography in Clinical Stage IA Lung Adenocarcinoma  Hirofumi Uehara, MD,
Lung cancer randomized controlled trials should compare stereotactic body radiation therapy with observation, NOT surgery  Raja M. Flores, MD  The Journal.
Respect the aorta The Journal of Thoracic and Cardiovascular Surgery
Salvage surgery for advanced non–small cell lung cancer after response to gefitinib  Tomoyuki Hishida, MD, Kanji Nagai, MD, Tetsuya Mitsudomi, MD, Kohei.
A clinicopathological study of resected adenocarcinoma 2 cm or less in diameter  Norihiko Ikeda, MD, PhD, Junichi Maeda, MD, Koichi Yashima, MD, Masahiro.
Samuel Kim, MD  The Journal of Thoracic and Cardiovascular Surgery 
Visceral Pleural Invasion Is Not a Significant Prognostic Factor in Patients With a Part- Solid Lung Cancer  Aritoshi Hattori, MD, Kenji Suzuki, MD, Takeshi.
Presentation transcript:

Radiographically determined noninvasive adenocarcinoma of the lung: Survival outcomes of Japan Clinical Oncology Group 0201  Hisao Asamura, MD, Tomoyuki Hishida, MD, Kenji Suzuki, MD, Teruaki Koike, MD, Kenichi Nakamura, MD, Masahiko Kusumoto, MD, Kanji Nagai, MD, Hirohito Tada, MD, Tetsuya Mitsudomi, MD, Masahiro Tsuboi, MD, Taro Shibata, MSc, Haruhiko Fukuda, MD  The Journal of Thoracic and Cardiovascular Surgery  Volume 146, Issue 1, Pages 24-30 (July 2013) DOI: 10.1016/j.jtcvs.2012.12.047 Copyright © 2013 The American Association for Thoracic Surgery Terms and Conditions

Figure 1 Calculation of the C/T ratio to define radiologic noninvasive lung cancer on TSCT. The maximum diameter of consolidation (C) is divided by the maximum tumor diameter (T) to give the C/T ratio. GGO, Ground-glass opacity; C/T, consolidation/tumor; TSCT, thin-section computed tomography. The Journal of Thoracic and Cardiovascular Surgery 2013 146, 24-30DOI: (10.1016/j.jtcvs.2012.12.047) Copyright © 2013 The American Association for Thoracic Surgery Terms and Conditions

Figure 2 Overall (A) and relapse-free (B) survival curves for the entire group (cT1a-b, ≤3.0 cm, n = 545). OS, Overall survival; RFS, relapse-free survival. The Journal of Thoracic and Cardiovascular Surgery 2013 146, 24-30DOI: (10.1016/j.jtcvs.2012.12.047) Copyright © 2013 The American Association for Thoracic Surgery Terms and Conditions

Figure 3 Overall (A) and relapse-free (B) survival curves for radiologically noninvasive (n = 121) and invasive (n = 424) adenocarcinomas based on a C/T ratio of 0.50 or less in cT1a-b (≤3.0 cm) for noninvasiveness on TSCT. The differences in overall and relapse-free survival are statistically significant (P < .001 and < .001, respectively). OS, Overall survival; RFS, relapse-free survival; C/T, consolidation/tumor; TSCT, thin-section computed tomography. The Journal of Thoracic and Cardiovascular Surgery 2013 146, 24-30DOI: (10.1016/j.jtcvs.2012.12.047) Copyright © 2013 The American Association for Thoracic Surgery Terms and Conditions

Figure 4 Overall (A) and relapse-free (B) survival curves for the cT1a (≤2.0 cm) group (n = 289). OS, Overall survival; RFS, relapse-free survival. The Journal of Thoracic and Cardiovascular Surgery 2013 146, 24-30DOI: (10.1016/j.jtcvs.2012.12.047) Copyright © 2013 The American Association for Thoracic Surgery Terms and Conditions

Figure 5 Overall (A) and relapse-free (B) survival curves for radiologically noninvasive (n = 35) and invasive (n = 254) adenocarcinomas based on a C/T ratio of 0.25 or less in cT1a (≤2.0 cm) for noninvasiveness on TSCT. The differences in overall and relapse-free survival are not statistically significant (P = .259 and .106, respectively). OS, Overall survival; RFS, relapse-free survival; C/T, consolidation/tumor; TSCT, thin-section computed tomography. The Journal of Thoracic and Cardiovascular Surgery 2013 146, 24-30DOI: (10.1016/j.jtcvs.2012.12.047) Copyright © 2013 The American Association for Thoracic Surgery Terms and Conditions

Figure 6 Overall (A) and relapse-free (B) survival curves for radiologically noninvasive (n = 54) and invasive (n = 200) adenocarcinomas based on a C/T ratio ≤0.5 in cT1b (>2.0-3.0 cm) for noninvasiveness on TSCT. The differences in overall and relapse-free survival are statistically significant (P = .003 and .003, respectively). OS, Overall survival; RFS, relapse-free survival; C/T, consolidation/tumor; TSCT, thin-section computed tomography. The Journal of Thoracic and Cardiovascular Surgery 2013 146, 24-30DOI: (10.1016/j.jtcvs.2012.12.047) Copyright © 2013 The American Association for Thoracic Surgery Terms and Conditions